Renal cell carcinoma in kidney transplant recipients and dialysis patients

Hyung Ho Lee, Kyung Hwa Choi, Seung Choul Yang, WoongKyu Han

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: In a group of surgery patients diagnosed with renal cell cancer, those who underwent dialysis were compared with those who received a kidney transplant. Materials and Methods: The 43 subjects included in this study were patients who had been undergoing dialysis because of end-stage renal disease or had undergone kidney transplantation. The patients were diagnosed with renal cell carcinoma (RCC) during follow-up and underwent radical nephrectomy from May 1996 to December 2010. Their medical records were retrospectively analyzed as part of the study. Results: In the transplantation group, the renal replacement therapy period averaged 54 months, and the period from transplantation to RCC averaged 119 months (range, 0 to 264 months). In the dialysis group, RCC was observed after an average of 124 months (range, 2 to 228 months) of dialysis, and nephrectomy was then conducted. Acquired cystic kidney disease (ACKD) was found more frequently in the dialysis group, and it had a statistically relevant effect on the occurrence of RCC by comparison with the transplantation group (p<0.01). Conclusions: Although the incidence rate of ACKD was significantly higher in the dialysis group among patients undergoing surgery for RCC, cancer was found even without ACKD development in some transplant recipients. Considering that the transplant recipients also underwent dialysis, an informative prospective study will be necessary to determine whether other immunosuppressive agents besides ACKD may function as a cancer risk factor.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalKorean Journal of Urology
Volume53
Issue number4
DOIs
Publication statusPublished - 2012 Apr 1

Fingerprint

Renal Cell Carcinoma
Dialysis
Cystic Kidney Diseases
Kidney
Transplantation
Nephrectomy
Renal Replacement Therapy
Immunosuppressive Agents
Transplant Recipients
Kidney Transplantation
Chronic Kidney Failure
Medical Records
Prospective Studies
Transplants
Incidence
Neoplasms

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Lee, Hyung Ho ; Choi, Kyung Hwa ; Yang, Seung Choul ; Han, WoongKyu. / Renal cell carcinoma in kidney transplant recipients and dialysis patients. In: Korean Journal of Urology. 2012 ; Vol. 53, No. 4. pp. 229-233.
@article{e311b57e7eb94c42a353eebe218bb935,
title = "Renal cell carcinoma in kidney transplant recipients and dialysis patients",
abstract = "Purpose: In a group of surgery patients diagnosed with renal cell cancer, those who underwent dialysis were compared with those who received a kidney transplant. Materials and Methods: The 43 subjects included in this study were patients who had been undergoing dialysis because of end-stage renal disease or had undergone kidney transplantation. The patients were diagnosed with renal cell carcinoma (RCC) during follow-up and underwent radical nephrectomy from May 1996 to December 2010. Their medical records were retrospectively analyzed as part of the study. Results: In the transplantation group, the renal replacement therapy period averaged 54 months, and the period from transplantation to RCC averaged 119 months (range, 0 to 264 months). In the dialysis group, RCC was observed after an average of 124 months (range, 2 to 228 months) of dialysis, and nephrectomy was then conducted. Acquired cystic kidney disease (ACKD) was found more frequently in the dialysis group, and it had a statistically relevant effect on the occurrence of RCC by comparison with the transplantation group (p<0.01). Conclusions: Although the incidence rate of ACKD was significantly higher in the dialysis group among patients undergoing surgery for RCC, cancer was found even without ACKD development in some transplant recipients. Considering that the transplant recipients also underwent dialysis, an informative prospective study will be necessary to determine whether other immunosuppressive agents besides ACKD may function as a cancer risk factor.",
author = "Lee, {Hyung Ho} and Choi, {Kyung Hwa} and Yang, {Seung Choul} and WoongKyu Han",
year = "2012",
month = "4",
day = "1",
doi = "10.4111/kju.2012.53.4.229",
language = "English",
volume = "53",
pages = "229--233",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "4",

}

Renal cell carcinoma in kidney transplant recipients and dialysis patients. / Lee, Hyung Ho; Choi, Kyung Hwa; Yang, Seung Choul; Han, WoongKyu.

In: Korean Journal of Urology, Vol. 53, No. 4, 01.04.2012, p. 229-233.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Renal cell carcinoma in kidney transplant recipients and dialysis patients

AU - Lee, Hyung Ho

AU - Choi, Kyung Hwa

AU - Yang, Seung Choul

AU - Han, WoongKyu

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Purpose: In a group of surgery patients diagnosed with renal cell cancer, those who underwent dialysis were compared with those who received a kidney transplant. Materials and Methods: The 43 subjects included in this study were patients who had been undergoing dialysis because of end-stage renal disease or had undergone kidney transplantation. The patients were diagnosed with renal cell carcinoma (RCC) during follow-up and underwent radical nephrectomy from May 1996 to December 2010. Their medical records were retrospectively analyzed as part of the study. Results: In the transplantation group, the renal replacement therapy period averaged 54 months, and the period from transplantation to RCC averaged 119 months (range, 0 to 264 months). In the dialysis group, RCC was observed after an average of 124 months (range, 2 to 228 months) of dialysis, and nephrectomy was then conducted. Acquired cystic kidney disease (ACKD) was found more frequently in the dialysis group, and it had a statistically relevant effect on the occurrence of RCC by comparison with the transplantation group (p<0.01). Conclusions: Although the incidence rate of ACKD was significantly higher in the dialysis group among patients undergoing surgery for RCC, cancer was found even without ACKD development in some transplant recipients. Considering that the transplant recipients also underwent dialysis, an informative prospective study will be necessary to determine whether other immunosuppressive agents besides ACKD may function as a cancer risk factor.

AB - Purpose: In a group of surgery patients diagnosed with renal cell cancer, those who underwent dialysis were compared with those who received a kidney transplant. Materials and Methods: The 43 subjects included in this study were patients who had been undergoing dialysis because of end-stage renal disease or had undergone kidney transplantation. The patients were diagnosed with renal cell carcinoma (RCC) during follow-up and underwent radical nephrectomy from May 1996 to December 2010. Their medical records were retrospectively analyzed as part of the study. Results: In the transplantation group, the renal replacement therapy period averaged 54 months, and the period from transplantation to RCC averaged 119 months (range, 0 to 264 months). In the dialysis group, RCC was observed after an average of 124 months (range, 2 to 228 months) of dialysis, and nephrectomy was then conducted. Acquired cystic kidney disease (ACKD) was found more frequently in the dialysis group, and it had a statistically relevant effect on the occurrence of RCC by comparison with the transplantation group (p<0.01). Conclusions: Although the incidence rate of ACKD was significantly higher in the dialysis group among patients undergoing surgery for RCC, cancer was found even without ACKD development in some transplant recipients. Considering that the transplant recipients also underwent dialysis, an informative prospective study will be necessary to determine whether other immunosuppressive agents besides ACKD may function as a cancer risk factor.

UR - http://www.scopus.com/inward/record.url?scp=84859961764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859961764&partnerID=8YFLogxK

U2 - 10.4111/kju.2012.53.4.229

DO - 10.4111/kju.2012.53.4.229

M3 - Article

VL - 53

SP - 229

EP - 233

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 4

ER -